Medicale (MCLE) Return on Capital Employed (2021 - 2024)

Medicale has reported Return on Capital Employed for 4 years, with the latest figure at 228.78% in Q4 2024.

• For the quarter ending Q4 2024, Return on Capital Employed fell 17816.0% year-over-year to 228.78%; the trailing twelve-month figure through Dec 2024 stood at 228.78% (down 17816.0% YoY), and the FY2024 full-year result was 356.44%, changed N/A from the prior year.
• Return on Capital Employed for Q4 2024 stood at 228.78%, down from 356.44% in the prior quarter.
• The five-year high for Return on Capital Employed was 411.42% in Q1 2024, with the low at 92.32% in Q3 2023.
• Historically, Return on Capital Employed has averaged 238.52% across 4 years, with a median of 201.71% in 2021.
• The largest YoY upside for Return on Capital Employed was 26412 bps in 2024 against a maximum downside of 17816 bps in 2024.
• Medicale's Return on Capital Employed stood at 201.71% in 2021, then tumbled by 54 bps to 92.38% in 2022, then soared by 341 bps to 406.94% in 2023, then plunged by 44 bps to 228.78% in 2024.
• The last three Return on Capital Employed figures came in at 228.78% (Q4 2024), 356.44% (Q3 2024), and 382.26% (Q2 2024), per Business Quant data.